71
Views
1
CrossRef citations to date
0
Altmetric
Corrigendum

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]

Page 515 | Published online: 06 Aug 2019
This article refers to:
HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer

Bretoni A, Ferrario L, Foglia E. Clinicoecon Outcomes Res. 2019;11:283–300.

The authors of this paper have advised us that there is a typographical error in one of the headings in Table 4. Table 4 occupies two pages and while being continued from page 292 onto page 293, a wrong table header was recorded. The table heading “Effectiveness profile” should instead be replaced by “Equity aspects” on page 293.